Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

What Happens To The Kinahan Ca...

00:20:10

What Happens To The Kinahan Cartel Now?

Newstalk Daily

00:20:10


Do we need more non-religious...

00:10:54

Do we need more non-religious school options?

The Hard Shoulder

00:10:54


Will we need to import more je...

00:07:38

Will we need to import more jet fuel from the United States?

The Hard Shoulder

00:07:38


Do we need to grow more food f...

00:07:48

Do we need to grow more food for our own security?

The Hard Shoulder

00:07:48